Glucose Biosensor Market Is Expected To Reach USD 31.0 Billion By 2022: Hexa Reports

Hexa Reports
Market Research Reports and Insightful Company Profiles
Glucose Biosensor Market Share, Size, Market Insights,
Trends, Market Review and Outlook, Overview And
Segment Forecasts To 2022
Global Glucose Biosensor Market is expected to reach USD 31.0 billion by 2022, according to a new
report by Grand View Research Inc. The global Glucose Biosensor Market is anticipated to witness
lucrative growth during the period of 2015 to 2022.
Some key factors attributing to the growth of this market include the increasing incidence of diabetes
across the globe, development of technologically advanced products, growing demand for minimally
and non-invasive products, patient awareness levels, and the need for early diabetes detection.
However, presence of other alternatives for management of the diabetes, such as laboratory methods is
expected to restrict market growth.
Browse Detail Report With TOC @
http://www.hexareports.com/report/glucose-biosensor-market/details
The glucose biosensors industry by end-use is segmented on the basis of its use in hospitals, homecare
diagnostics, and others including research institutes, diagnostics, and clinical laboratories. The homecare
diagnostics Glucose Biosensor Market is projected to flourish over the forecast period. Ease-of-use,
quick results, and low costs of the tests are some aspects supporting market growth. On the other hand,
the hospital-based Glucose Biosensor Market is projected to grow at a significant CAGR of 10.3% during
the period 2015 to 2022.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Further key findings from the study suggest:
North America led the market, in terms of value, with a share of about 37% in 2015. High disease burden
and the subsequent need to curb associated healthcare expenditure in the U.S., has resulted in this
country account for a large revenue share of the North American market in 2014. According to the
Centers of Disease Control (CDC), around 22.3 million people in the U.S. were estimated to be diagnosed
with diabetes in the year 2013.
Asia Pacific is anticipated to witness lucrative growth during the forecast period. This market is
projected to grow rapidly during the period 2015 to 2022. China and India are expected to spearhead
market growth in this region.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/112495
The homecare diagnostics Glucose Biosensor Market was the largest in 2014. The segment is anticipated
to grow at a rapid CAGR during the forecast period. As of 2015, the market was led by North America
owing to the region's highest disease burden and homecare diagnostics adoption rates.
The Glucose Biosensor Market comprises several local as well as global players. Some major players of
this industry include Roche, Bayer and LifeScan, Inc.
Table Of Content
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Glucose biosensors Market - Industry Summary and Key Buying Criteria, 2012 - 2020
Chapter 3. Glucose biosensors Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2012-2020
3.3. Glucose biosensors: Market dynamics
3.4. Glucose biosensors market: Industry trend analysis
3.5. Glucose biosensors Market - PESTEL Analysis
3.6. Glucose biosensors Industry analysis - Porter's Five Forces Model
3.7. Glucose biosensors: Company Market Share Analysis (%), 2014
3.8. Key opportunities prioritized
Browse All Healthcare Market Research Related Reports @
http://www.hexareports.com/category/healthcare-market
Hexa Reports
Market Research Reports and Insightful Company Profiles
Chapter 4. Glucose Biosensors End-User Application Outlook
4.1. Glucose Biosensors Revenue Share (%) Analysis, by End-User Application, 2014 & 2022
4.2. Hospital
4.3. Homecare Diagnostics
4.4. Others
Chapter 5. Glucose Biosensors Regional Outlook
5.1. Glucose Biosensors Market Share (%) Analysis, by Region, 2014 & 2022
5.2. North America
5.3. Europe
5.4. Asia Pacific
5.5. MEA
5.6. Latin America
Chapter 6. Competitive Landscape
6.1. Roche Diagnostics
6.2. LifeScan Inc.
6.3. Abbott Laboratories
6.4. Bayer
6.5. Medtronic Inc.
6.6. Pinnacle Medical Solutions Inc.
6.7. AgaMatrix Inc.
6.8. Sanofi S.A.
6.9. BioSense Medical Devices, LLC
Browse Full Report @ http://www.hexareports.com/report/glucose-biosensor-market/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit our Blog: http://hexareports.blogspot.com/

Global Glucose Biosensor Market is expected to reach USD 31.0 billion by 2022, according to a new report by Grand View Research Inc. The global Glucose Biosensor Market is anticipated to witness lucrative growth during the period of 2015 to 2022.